We are building reversible cryopreservation technology to solve the organ procurement and matching problem.
Cryopreservation is already essential to modern medicine — powering IVF and life-saving stem cell therapies.
Now, we’re extending this technology to whole human organs — transforming hours of viability into weeks, or months, however long is necessary — so that no donated organ is lost to logistics, and no patient dies waiting.
By solving this immediate need, we de-risk and build the foundation for what comes next: whole-body reversible cryopreservation. We're pausing molecular motion to give patients a bridge to future cures.
Company Details
- Employees
- 36
- Address
- San Francisco , California , Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.untillabs.com/
- Keywords
- cryopreservation, cryopreservation research, controlled rate freezers, donor organ preservation.
- HQ
- San Francisco , California
Until Questions
Until's website is https://www.untillabs.com/
Until's LinkedIn profile is https://www.linkedin.com/company/untillabs
Until has
36 employees.
View email and phone details for 36
employees at Until.
Until's industry is
Biotechnology Research
Until's top competitors are
Fable Security,
Bettercomp,
Age1,
Cradle,
Cradle Inc.,
The Longevity Fund,
Streamline Ai,
Imaginable Solutions,
Cradle,
Hypernatural.
Until's categories are Biotechnology Research
